As of 2024-12-11, the EV/EBITDA ratio of Xphyto Therapeutics Corp (XPHY.CN) is -9.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XPHY.CN's latest enterprise value is 54.15 mil CAD. XPHY.CN's TTM EBITDA according to its financial statements is -5.82 mil CAD. Dividing these 2 quantities gives us the above XPHY.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.6x - 4.9x | 3.8x |
| Forward P/E multiples | 3.2x - 3.9x | 3.6x |
| Fair Price | (0.23) - (0.27) | (0.25) |
| Upside | -146.2% - -153.9% | -151.2% |
| Date | EV/EBITDA |